Literature DB >> 26659846

[Surgical techniques in mitral valve diseases. Reconstruction and/or replacement].

T Noack1, F-W Mohr2.   

Abstract

Mitral valve (MV) disease is one of the most common heart valve diseases. The surgical and interventional treatment for MV disease requires a multidisciplinary approach. For primary mitral valve regurgitation (MVR) surgical MV repair is the treatment of choice, which can be performed with an excellent outcome and long-term survival in reference centers. The surgical technique used for MV repair depends on the pathological mechanism, the morphological dimensions of the MV, the operative risk and the expertise of the cardiac surgeon. The surgical and interventional treatment of secondary MVVR is the subject of on-going discussions. In patients with moderate secondary MVR undergoing coronary artery bypass grafting, concomitant MV repair should be performed. In the presence of severe secondary MR with risk factors for failure of MV repair, patients should consider having MV replacement. In the rare cases of patients presenting with mitral valve stenosis (MVS) MV repair can be considered in young patients and who are most often treated with MV replacement. The choice between biological or mechanical MV replacement depends on the pathophysiology, the comorbidities, the amount of anticoagulation necessary and the age of the patient. New percutaneous techniques for MV replacement offer new treatment options for reoperation in high-risk patients.

Entities:  

Keywords:  Heart surgery; Mitral valve regurgitation; Mitral valve repair; Mitral valve replacement; Mitral valve stenosis

Mesh:

Year:  2016        PMID: 26659846     DOI: 10.1007/s00059-015-4385-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  39 in total

1.  Impact of hospital annual mitral procedural volume on mitral valve repair rates and mortality.

Authors:  Christina M Vassileva; Theresa Boley; Stephen Markwell; Stephen Hazelrigg
Journal:  J Heart Valve Dis       Date:  2012-01

2.  Reducing operative mortality in valvular reoperations: the "valve in ring" procedure.

Authors:  Filip Casselman; Sebastiaan Martens; Bernard De Bruyne; Ivan Degrieck
Journal:  J Thorac Cardiovasc Surg       Date:  2010-09-19       Impact factor: 5.209

3.  Significant LVOT obstruction after mitral valve in ring procedure.

Authors:  Said Alsidawi; Mackram F Eleid; Charanjit S Rihal; Vuyisile T Nkomo; Sorin Pislaru
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-09-28       Impact factor: 6.875

4.  Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients.

Authors:  Joerg Seeburger; Michael Andrew Borger; Volkmar Falk; Thomas Kuntze; Markus Czesla; Thomas Walther; Nicolas Doll; Friedrich Wilhelm Mohr
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-30       Impact factor: 4.191

5.  Four-dimensional modelling of the mitral valve by real-time 3D transoesophageal echocardiography: proof of concept.

Authors:  Thilo Noack; Chirojit Mukherjee; Philipp Kiefer; Fabian Emrich; Marcel Vollroth; Razvan Ioan Ionasec; Ingmar Voigt; Helene Houle; Joerg Ender; Martin Misfeld; Friedrich Wilhelm Mohr; Joerg Seeburger
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-10-31

6.  Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries.

Authors:  Christina M Vassileva; Gregory Mishkel; Christian McNeely; Theresa Boley; Stephen Markwell; Steven Scaife; Stephen Hazelrigg
Journal:  Circulation       Date:  2013-04-08       Impact factor: 29.690

7.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

8.  Rate of repair in minimally invasive mitral valve surgery.

Authors:  Patrick Perier; Wolfgang Hohenberger; Fitsum Lakew; Gerhard Batz; Anno Diegeler
Journal:  Ann Cardiothorac Surg       Date:  2013-11

Review 9.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.

Authors:  Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Bogdan A Popescu; Thor Edvardsen; Luc A Pierard; Luigi Badano; Jose L Zamorano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-06-03       Impact factor: 6.875

10.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

View more
  1 in total

1.  [Cardioband®: Where do we stand, who are suitable patients?]

Authors:  C Frerker; T Schmidt; R Pfister; M I Körber; V Mauri; M Wösten; S Baldus
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.